πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6410039

Protective topical composition, products including the same, and methods

First Scientific, Inc. Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410023

Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essen

The United States of America Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410010

Recombinant P53 adenovirus compositions

The Board of Regents of the University of Texas System Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410029

2-methoxyestradiol-induced apoptosis in cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410721

Polynucleotide decoys that inhibit MHC-II expression and uses thereof

The Regents of the University of California Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410603

Active topical skin protectants using combinations of reactive nanoparticles and polyoxome

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410594

Substituted cyclopentane compounds useful as neuraminidase inhibitors

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410537

Compositions having neuroprotective and analgesic activity

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410519

Scar reduction

United States Surgical Corporation Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410510

Administration modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410320

Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kid

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410056

Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6410049

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo d

The Regents of the University of California Β· Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6407133

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6407132

Substituted imidazole derivatives and their use as histamine H3 receptor ligands

The James Black Foundation Limited Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6407129

Azole compounds, their production and their use

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6407116

Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6407108

1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions c

Almirall Prodesfarma S.A. Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6406887

Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6406717

Rapid-melt semi-solid compositions, methods of making same and methods of using same

Capricorn Pharma Inc. Β· Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6403672

Preparation and use of photopolymerized microparticles

The Regents of the University of Technology Office of Technology Transfer Β· Granted Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6403595

Sulfonamide derivatives, processes for producing the same and utilization thereof

Takeda Chemical Industries Ltd. Β· Granted Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6403769

Fusion proteins that include antibody and nonantibody portions

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 11 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6399762

Methods and compositions for diagnosing and treating chromosome -18p related disorders

The Regents of the University of California Β· Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired